Publications by authors named "I Hospital"
Purpose: This study investigated the incidence of pneumococcal pneumonia requiring hospitalisation among middle-aged and older adults with and without specific underlying medical conditions, evaluating the influence of these conditions in the risk of developing pneumonia.
Methods: Population-based prospective cohort study included 2,025,730 individuals ≥ 50 years around Catalonia, Spain. The Catalonian information system for the development of research in primary care (SIDIAP) was used to establish baseline characteristics of the cohort (comorbidities and underlying medical conditions).
Background: Clinical benefits using the 23-valent pneumococcal polysaccharide vaccine (PPsV23) or the 13-valent pneumococcal conjugate vaccine (PCV13) in adults are controversial. This study investigated clinical effectiveness for both PPsV23 and PCV13 in preventing pneumonia among middle-aged and older adults.
Methods: Population-based cohort study involving 2,025,730 persons ≥50 years in Catalonia, Spain, who were prospectively followed between 01/01/2015 and 31/12/2016.
Article Synopsis
- The study examined the prevalence of risk factors for pneumococcal disease among middle-aged and older adults in Catalonia, highlighting a lack of updated population-based data.
- Approximately 48.2% of the 2,033,465 individuals studied had at least one risk condition, with higher prevalence in men and older age groups; 8.7% had high-risk conditions like immunocompromising issues.
- The findings suggest that nearly 50% of adults aged 50 and older in Catalonia are at risk for pneumococcal disease, indicating a significant public health concern.
There is scarce data about pneumococcal vaccination coverages among adults in recent years. We investigated current pneumococcal vaccination coverages in Catalonia, Spain, with a cross-sectional population-based study including 2,033,465 individuals aged 50 y or older assigned to the Catalonian Health Institute at 01/01/2015 (date of survey). A previously validated institutional research clinical Database was used to classify study subjects by their vaccination status for both 23-valent pneumococcal polysaccharide vaccine (PPSV23) and 13-valent pneumococcal conjugate vaccine (PCV13), to identify comorbidities and underlying conditions, and establish the risk stratum of each individual: High risk stratum: functional or anatomic asplenia, cochlear implants, CSF leaks, or immunocompromising conditions; medium risk stratum: immunocompetent persons with history of chronic cardiac or respiratory disease, liver disease, diabetes mellitus, alcoholism and/or smoking; low risk stratum: persons without high or medium risk conditions.
View Article and Find Full Text PDFObjective: To assess whether passive smoking exposure at home is a risk factor for community-acquired pneumonia (CAP) in adults.
Setting: A population-based case-control study was designed in a Mediterranean area with 860 000 inhabitants >14 years of age.
Participants: 1003 participants who had never smoked were recruited.